General description
All-trans retinoic acid (ATRA) is an antineoplastic agent derived from retinoic acid, used in the treatment of acute promyelocytic leukaemia (APML).
INN
Tretinoin
Medicine type
Chemical agent
EML status history
First added in 2015
(TRS
994)
for
Acute myeloid leukaemia with recurrent genetic abnormalities
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
- Oral > Solid: 10 mg capsule